AirGo™ Respiratory Monitoring in Lung Resection

September 18, 2026 updated by: Arianna Farronato, Fondazione IRCCS Policlinico San Matteo di Pavia

Perioperative Real-time Respiratory Assessment in Lung Resections With a New Device: the AirGoTM System

Patients undergoing lung resection surgery may experience changes in respiratory function during the perioperative period. Current monitoring methods provide important clinical information but are often limited to specific time points and may not allow continuous assessment of ventilation. This study aims to evaluate the feasibility and usefulness of the AirGo™ wearable respiratory monitoring system in patients undergoing anatomical lung resection (lobectomy or segmentectomy). AirGo™ is a non-invasive, CE-marked device that continuously measures respiratory parameters, including minute ventilation and respiratory rate, through a chest-worn sensor. Participants will wear the AirGo™ device before surgery and during the postoperative period. Respiratory parameters collected by AirGo™ will be analyzed at predefined time points and compared with standard clinical monitoring methods routinely used in postoperative care, including pulse oximetry and telemetry. The primary objective is to assess changes in mean minute ventilation from the preoperative period to the first postoperative day. Secondary objectives include evaluating perioperative respiratory trends, patient comfort and compliance with the device, and the agreement between AirGo™ measurements and standard monitoring systems. The results of this study may help determine whether continuous non-invasive respiratory monitoring can improve the assessment and management of patients undergoing lung surgery.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lombardy
      • Pavia, Lombardy, Italy, 27100
        • Recruiting
        • Fondazione IRCCS Policlinico San Matteo di Pavia
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients scheduled for minimally invasive anatomical lung resection, specifically Video-Assisted thoracic surgery (VATS) lobectomy or segmentectomy, performed for diagnostic or curative purposes;
  • Patients capable of performing a spirometry
  • Age between 21 and 80 years
  • Patient consented to the study by signing the consent

Exclusion Criteria:

  • Pre-operative presence of pneumothorax and/or pleural effusion
  • Pregnancy
  • Severe trauma or major surgery in the last year previous cardio-thoracic surgery (including spinal surgery)
  • Preoperative chest pain or low back pain,
  • Obesity (BMI >30)
  • Emergency surgery
  • Patients scheduled for anatomical lung resection
  • Specifically thoracotomy lobectomy or segmentectomy
  • Scheduled bi-lobectomy or pneumonectomy or extended sleeve lobectomy
  • Lung resection extended to the chest wall
  • Inability to follow procedures
  • Insufficient knowledge of project language (italian)
  • Inability to give consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: AirGo Respiratory Monitoring

Participants undergoing minimally invasive anatomical lung resection (VATS, lobectomy or segmentectomy) will undergo perioperative respiratory monitoring using the AirGo™ device in addition to standard clinical care. Respiratory parameters, including minute ventilation and respiratory rate, will be assessed at predefined timepoints before and after surgery.

AirGo™ is a non-invasive wireless wearable respiratory monitoring system used for continuous measurement of respiratory parameters, including minute ventilation and respiratory rate, during the perioperative period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Mean Minute Ventilation
Time Frame: From preoperative baseline to the first postoperative day

Difference in mean minute ventilation (L/min), measured by the AirGo™ system during a 60-minute resting recording, between the preoperative assessment and the first postoperative day.

From preoperative baseline to the first postoperative day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Mean Minute Ventilation Over Perioperative Timepoints
Time Frame: Preoperative baseline, first postoperative day, second postoperative day, and one month after intervention

Change in mean minute ventilation (L/min) measured by the AirGo™ system at preoperative baseline, first postoperative day, second postoperative day, and one month after surgery

Preoperative baseline, first postoperative day, second postoperative day, and one month after intervention
Change in Mean Resting Respiratory Rate
Time Frame: Preoperative baseline, first postoperative day, second postoperative day, and one month after intervention

Change in mean resting respiratory rate (breaths/min) measured by continuous AirGo™ monitoring at preoperative baseline, first postoperative day, second postoperative day, and one month after surgery.

Preoperative baseline, first postoperative day, second postoperative day, and one month after intervention
Patient-Reported Comfort With AirGo™ Monitoring
Time Frame: During the postoperative period

Patient-reported comfort during AirGo™ monitoring assessed using a standardized Numerical Rating Scale (NRS)

During the postoperative period
Agreement Between AirGo™ and Standard Postoperative Monitoring for Respiratory Rate
Time Frame: During the postoperative monitoring period on postoperative days 1 and 2

Agreement between respiratory rate measured by the AirGo™ system and respiratory rate obtained from standard postoperative monitoring, including pulse oximetry and telemetry, during overlapping observation periods.

During the postoperative monitoring period on postoperative days 1 and 2
AirGo™ Device-Related Adverse Events
Time Frame: From device application through 1 month after intervention

Number of participants experiencing device-related adverse events, including skin irritation, discomfort, interference with surgical wounds, and premature discontinuation of monitoring.

From device application through 1 month after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 7, 2026

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

April 1, 2028

Study Registration Dates

First Submitted

September 4, 2026

First Submitted That Met QC Criteria

September 18, 2026

First Posted (Actual)

September 24, 2026

Study Record Updates

Last Update Posted (Actual)

September 24, 2026

Last Update Submitted That Met QC Criteria

September 18, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe